mitchell_web

Data science firm Genomics Plc names new Chief Strategy Officer

March 10, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing genomics, pharma

Data science firm Genomics Plc, which lays claim to “the world’s largest genomic database”, has welcomed Mitchell Harris to the …

conference_peach

The American Academy of Allergy, Asthma and Immunology calls off its 2020 Annual Meeting due to coronavirus concerns

March 10, 2020
Medical Communications, Research and Development Big Pharma, allergy, america, asthma, immunology

The American Academy of Allergy, Asthma and Immunology (AAAAI) has called off its 2020 Annual Meeting that was schedule to …

boehringer_biberach_germany_copy

Boehringer’s TKI inhibitor Ofev gets FDA approval for chronic fibrosing interstitial lung diseases with a progressive phenotype

March 10, 2020
Manufacturing and Production, Sales and Marketing Boehringer, FDA, ofev, pharma

The FDA has green-lit Boehringer Ingelheim’s multi-targeted tyrosine kinase inhibitor Ofev (nintedanib) in the treatment of chronic fibrosing interstitial lung …

48610088067_59be70df49_b

Anti-HIV drug PrEP has 30% lower concentration levels in pregnant African adolescents and young women

March 10, 2020
Manufacturing and Production AIDS, HIV, PrEP, PrEP HIV, insulin

Pregnant African adolescents and young women who took the HIV drug PrEP were found to have 30% lower levels of …

4773288007_96679a394b_b

Fast-acting mealtime insulin approved for children with diabetes in Canada

March 10, 2020
Manufacturing and Production Type 1 diabetes, diabetes, insulin, insulin pump, type 2 diabetes

Health Canada has approved Novo Nordik’s Fiasp, a faster acting mealtime insulin, for children aged 2 and above with type …

medium_ab

Alligator Bioscience hires Chief Financial Officer in interim capacity

March 9, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alligator Bioscience, pharma

Andreas Johannesson has been announced as Alligator Bioscience’s new interim Chief Financial Officer (CFO), replacing ex-CFO Per-Olof Schrewelius who it …

lars_nieba-web-image_0

Dr Lars Nieba appointed interim Chief Executive Officer at Nordic Nanovector

March 9, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Nordic Nanovector has appointed Dr Lars Nieba as the interim Chief Executive Officer. He is currently the company’s Chief Technology …

chris-thatcher-headshot_750xx1602-2136-155-0_1

Chris Thatcher to step down as President and CEO of Neuronetics

March 9, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Neuronetics, Inc and Chris Thatcher, the President and CEO, have mutually agreed that he will step down from his positions …

cambridge_skyline

Biogen and Takeda forced to send employees home as coronavirus hits Massachusetts

March 9, 2020
Manufacturing and Production, Medical Communications Biogen, Takeda, coronavirus, pharma

Big pharma has been hit by the coronavirus (COVID-19) outbreak right on its doorstep, as two of the biggest names …

22087308493_cedb177b53_b

ACC.20 cancelled due to coronavirus fears

March 9, 2020
Manufacturing and Production, Medical Communications cardio, cardiology, cardiovascular

The American College of Cardiology has cancelled its upcoming ACC.20 event with the World Congress of Cardiology due to concerns …

what-is-pharmacovigilance-328154

The need for evolution in pharmacovigilance

March 9, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, pharma, pharmacovigilance

Pharmacovigilance is a critical function in ensuring public health, but is our current system built to tackle the challenges of …

palace-westminster-bridge-city

UK Government outlines emergency measures to tackle coronavirus

March 9, 2020
Sales and Marketing British Coronavirus, Chinese Coronavirus, Wuhan Coronavirus, coronavirus

The British Government has outlined its emergency legislation to tackle coronavirus in which people could leave work to become volunteers …

FDA authorises first therapy to tackle cortisol overproduction in Cushing’s disease

March 9, 2020
Sales and Marketing Cushing's disease, FDA, pharma

The FDA has moved to approve its first therapy to directly treat the overproduction of the hormone cortisol which is …

Coronavirus forcing Eli Lilly employees to work from home

March 9, 2020
Sales and Marketing Chinese Coroanvirus, Eli Lilly, Eli Lilly Coronavirus, Wuhan Coronavirus, coronavirus

Eli Lilly is asking some of its employees to work from home to stop the spread of coronavirus on its …

20181130-niaid-hiv-test

Uganda finalising clinical trials on new injectable HIV drug

March 9, 2020
Sales and Marketing AIDS, HIV, Uganda HIV, Uganda HIV/AIDS, uganda

Uganda is preparing to enter the final stages of developing a new HIV treatment to reduce stigma and discrimination of …

nice_new_london_office_internal_3_web

NICE shoots down Dupixent for severe asthma

March 9, 2020
Sales and Marketing Dupixent, NHS, NICE, Regeneron, Sanofi, UK, asthma

NICE, the NHS’ drug watchdog in England and Wales, has announced its decision not to recommend Sanofi and Regeneron’s IL-4 …

shutterstock

Scorpion venom added to CAR-T therapy increases efficacy in brain cancer, research shows

March 6, 2020
Medical Communications, Research and Development CAR-T, Cancer, brain cancer, glioblastoma, pharma

Chimeric antigen receptor T cell (CAR-T) therapy has gained much traction and attention in the past years for its innovative …

mental-3436232_1280

Lack of mental health treatment available for HIV patients in the UK

March 6, 2020
Medical Communications AIDS, HIV, HIV AIDS, HIV treatment, HIV/AIDS

A cross-party group of MPs have said that those with HIV do not have access to adequate mental health treatment. …

az_logo

Phase 3 failure for AstraZeneca’s Imfinzi combo in unresectable metastatic bladder cancer

March 6, 2020
Medical Communications, Research and Development AstraZeneca, Cancer, Imfinzi, bladder cancer, pharma, trial failure

New Phase 3 has been released by AstraZeneca, showing that the PD-L1 inhibitor Imfinzi (durvalumab), when combined with tremelimumab, failed …

The Gateway to Local Adoption Series

Latest content